Erythropoietin Terminated Phase 3 Trials for Lung Cancers / Anemias / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00310232Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
NCT00083486Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
NCT00422513A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
NCT00454246A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.
NCT00442416A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
NCT00210730The Duration Study